These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1804040)

  • 41. Cladribine (2-chloro-deoxyadenosine, CDA): an inhibitor of human B and T cell activation in vitro.
    Górski A; Grieb P; Korczak-Kowalska G; Wierzbicki P; Stepień-Sopniewska B; Mrowiec T
    Immunopharmacology; 1993; 26(3):197-202. PubMed ID: 7904595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppression of T and B cell responses by Pterodon pubescens seeds ethanolic extract.
    Cardoso CC; Pinto AC; Marques PR; Gayer CR; Afel MI; Coelho MG; Sabino KC
    Pak J Biol Sci; 2008 Oct; 11(19):2308-13. PubMed ID: 19137862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T-cell specific immunosuppression by prodigiosin isolated from Serratia marcescens.
    Han SB; Kim HM; Kim YH; Lee CW; Jang ES; Son KH; Kim SU; Kim YK
    Int J Immunopharmacol; 1998; 20(1-3):1-13. PubMed ID: 9717078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Increase of immunologic reactivity after administration of immunosuppressive agents as an expression of their effect on immunologic regulation].
    Schmassmann E; Herzer P; Lemmel EM
    Verh Dtsch Ges Inn Med; 1978; (84):1317-20. PubMed ID: 154241
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunomodulating influence of active metabolite of cyclophosphamide on human lymphocyte immunoglobulin biosynthesis in vitro.
    Górski A; Nowaczyk M; Korczak-Kowalska G; Rowiński W
    Transplantation; 1983 Jun; 35(6):577-81. PubMed ID: 6223417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective inhibition of various mitogen responses in human lymphocytes.
    Delespesse G; van Laarhoven JP; Collet H; De Bruyn CH
    Adv Exp Med Biol; 1984; 165 Pt B():205-10. PubMed ID: 6609533
    [No Abstract]   [Full Text] [Related]  

  • 47. Regulation of B cell function by the immunosuppressive agent leflunomide.
    Siemasko KF; Chong AS; Williams JW; Bremer EG; Finnegan A
    Transplantation; 1996 Feb; 61(4):635-42. PubMed ID: 8610393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose-response effects of 4-hydroperoxycyclophosphamide on human T and B cell function in vitro.
    Kodo H; Bonavida B; Colvin M; Gale RP
    Int J Immunopharmacol; 1985; 7(4):555-60. PubMed ID: 2931385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapamycin: in vitro profile of a new immunosuppressive macrolide.
    Sehgal SN; Bansbach CC
    Ann N Y Acad Sci; 1993 Jun; 685():58-67. PubMed ID: 8363266
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pharmacology of immunosuppressive agents].
    Genazzani E; Periti P
    Minerva Med; 1978 Aug; 69(38):2587-604. PubMed ID: 714259
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of cyclosporin A on T-dependent and T-independent immunoglobulin synthesis in vitro.
    Paavonen T; Häyry P
    Nature; 1980 Oct; 287(5782):542-4. PubMed ID: 6968408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A trial of utilizing antibodies as carriers of alkylating agents. I. Influence of cyclophosphamide and chlormethine on antigenic properties of serum proteins.
    Trzeciak J; Feluś E; Nolewajka E; Szaflarski J; Dudziak Z
    Arch Immunol Ther Exp (Warsz); 1975; 23(3):385-90. PubMed ID: 56161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The immunobiological effects of nitrogranulogen. I. Effect of nitrogranulogen on laboratory and clinical parameters in patients with primary glomerulopathies].
    Rancewicz Z; Imiela J; Juskowa J; Małecki R; Górski A
    Pol Arch Med Wewn; 1991 Aug; 86(2):68-74. PubMed ID: 1775393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variations in host defence mechanisms and blastogenesis in chickens and mice after rifamycin treatments.
    Alonso ML; Rojo JM; Moya MP; Ronda E
    Vet Immunol Immunopathol; 1982 Sep; 3(5):451-60. PubMed ID: 6183815
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of immunosuppressive chemotherapy on immune function in patients with malignant disease.
    Harris J; Sengar D; Stewart T; Hyslop D
    Cancer; 1976 Feb; 37(2 Suppl):1058-69. PubMed ID: 766953
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immunosuppression: bioligical bases and usage].
    Wilmanns W
    Internist (Berl); 1975 Oct; 16(10):451-9. PubMed ID: 1107251
    [No Abstract]   [Full Text] [Related]  

  • 57. Is the macrophage the site of the immunosuppressive action of rifampicin?
    Rook GA
    Tubercle; 1973 Dec; 54(4):291-5. PubMed ID: 4545454
    [No Abstract]   [Full Text] [Related]  

  • 58. [The effect of alkylating agents on DNA, RNA and protein synthesis by leukemic lymphocytes in vitro].
    Foldesh J; Djaldetti M
    Harefuah; 1979 Feb; 96(3):139-40. PubMed ID: 488806
    [No Abstract]   [Full Text] [Related]  

  • 59. Suppression of bovine T- and B-lymphocyte responses by fetuin, a bovine glycoprotein.
    Splitter GA; Everlith KM
    Cell Immunol; 1982 Jul; 70(2):205-18. PubMed ID: 6181899
    [No Abstract]   [Full Text] [Related]  

  • 60. Suppressive effect of antibiotic siomycin on antibody production.
    Ueno M; Furukawa S; Abe F; Ushioda M; Fujine K; Johki S; Hatori H; Ueda H
    J Antibiot (Tokyo); 2004 Sep; 57(9):590-6. PubMed ID: 15580960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.